Osmotic-Controlled Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder


( Last Updated : September 6, 2022)
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1630-000
Effective finish date:

Details


Question

  1. What is the clinical effectiveness of extended-release methylphenidate with an osmotic-controlled release oral delivery system for the treatment of attention-deficit/hyperactivity disorder in adults?

Key Message

We found 1 randomized controlled trial about the clinical effectiveness of extended-release methylphenidate with an osmotic-controlled release oral delivery system for the treatment of attention-deficit/hyperactivity disorder in adults.